Key result
SternaLock Blu significantly reduced maximum postoperative pain scores (1.6 vs 2.7, p<0.001) compared to traditional sternal wire closure in patients undergoing cardiovascular surgery.
Why the study?
This study aimed to evaluate the efficacy of SternaLock Blu on postoperative exercise capacity in patients undergoing cardiovascular surgery via median sternotomy.
Does sternal closure with SternaLock Blu improve postoperative exercise capacity and reduce pain in patients undergoing cardiovascular surgery via sternotomy compared to traditional sternal wire closure?
Cohort (n=116)
No
Does sternal closure with SternaLock Blu improve postoperative exercise capacity and reduce pain in patients undergoing cardiovascular surgery via sternotomy compared to traditional sternal wire closure?
Sternal closure with SternaLock Blu improves postoperative exercise capacity, reduces pain, and shortens ICU and hospital stays compared to traditional sternal wires in high-risk cardiovascular surgery patients.
Sternal rigid fixation was associated with better early mobility and shorter stays in selected high-risk patients; leaves open need for randomized confirmation before broader adoption.
Purpose This study aimed to evaluate the efficacy of postoperative exercise capacity of SternaLock Blu (Zimmer Biomet, USA) for post-sternotomy patients who underwent cardiovascular surgery. Methods We investigated 116 patients, including 35 women (mean age 70.3 ± 10.0 years), who underwent cardiovascular surgery by median sternotomy. Patients were candidate for using SternaLock Blu, such as obesity (body mass index > 30/kg/m2), insulin-dependent diabetes mellitus, steroid administrating, undergoing coronary bypass artery grafting used bilateral internal thoracic artery. These patients were categorized into those with SternaLock Blu (S group, n = 47) or with sternal wires only (N group, n = 69) for closing sternotomy, and their data were analyzed. Results Max Prince Henry Pain Scale (PHPS) was significantly low in the S group than in the N group (N vs. S = 2.7 ± 1.4 vs. 1.6 ± 1.7%, p < 0.001). Postoperative 6-min walk was significantly longer in the S group than in the N group (N vs. S = 346.2 ± 101.6 vs. 408.6 ± 104.6 m, p = 0.018). The length of intensive care unit (N vs. S = 4.9 ± 0.9 vs. 4.0 ± 1.2 days, p < 0.001) and hospitalization (N vs. S = 18.0 ± 5.0 vs. 15.2 ± 3.8 days, p = 0.006) were significantly shorter in the S group than in the N group. Conclusions SternaLock Blu could keep exercise capacity, and might help reduce postoperative pain and medical treatment period for patients who underwent cardiovascular surgery.
No takes yet. Share an insight, caveat, or question.
Tamura et al. (2023) conducted a cohort in Cardiovascular surgery via median sternotomy (n=116). SternaLock Blu vs. Traditional sternal wire closure was evaluated on Maximum Prince Henry Pain Scale (PHPS) score during hospitalization (p=<0.001). SternaLock Blu significantly reduced maximum postoperative pain scores (1.6 vs 2.7, p<0.001) compared to traditional sternal wire closure in patients undergoing cardiovascular surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: